Effect of Fecal Microbiota, Live-Jslm (REBYOTA [RBL]) on Health-Related Quality of Life in Patients With Recurrent Clostridioides difficile Infection: Results From the PUNCH CD3 Clinical Trial

BACKGROUND: Recurrence of Clostridioides difficile infection (rCDI) is common, prolonging disease morbidity and leading to poor quality of life. We evaluated disease-specific health-related quality of life (HRQL) in patients with rCDI treated with fecal microbiota, live-jslm (REBYOTA [RBL]; Rebiotix...

Descripción completa

Detalles Bibliográficos
Autores principales: Garey, Kevin W, Dubberke, Erik R, Guo, Amy, Harvey, Adam, Yang, Min, García-Horton, Viviana, Fillbrunn, Mirko, Wang, Hongjue, Tillotson, Glenn S, Bancke, Lindy L, Feuerstadt, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411038/
https://www.ncbi.nlm.nih.gov/pubmed/37564743
http://dx.doi.org/10.1093/ofid/ofad383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411038/
https://www.ncbi.nlm.nih.gov/pubmed/37564743
http://dx.doi.org/10.1093/ofid/ofad383

Ejemplares similares